BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 33597771)

  • 1. Simple and reliable detection of CRISPR-induced on-target effects by qgPCR and SNP genotyping.
    Weisheit I; Kroeger JA; Malik R; Wefers B; Lichtner P; Wurst W; Dichgans M; Paquet D
    Nat Protoc; 2021 Mar; 16(3):1714-1739. PubMed ID: 33597771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Deleterious On-Target Effects after HDR-Mediated CRISPR Editing.
    Weisheit I; Kroeger JA; Malik R; Klimmt J; Crusius D; Dannert A; Dichgans M; Paquet D
    Cell Rep; 2020 May; 31(8):107689. PubMed ID: 32460021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. qEva-CRISPR: a method for quantitative evaluation of CRISPR/Cas-mediated genome editing in target and off-target sites.
    Dabrowska M; Czubak K; Juzwa W; Krzyzosiak WJ; Olejniczak M; Kozlowski P
    Nucleic Acids Res; 2018 Sep; 46(17):e101. PubMed ID: 29878242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 Technology in Translational Biomedicine.
    Leonova EI; Gainetdinov RR
    Cell Physiol Biochem; 2020 Apr; 54(3):354-370. PubMed ID: 32298553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Based Technologies: Impact of RNA-Targeting Systems.
    Terns MP
    Mol Cell; 2018 Nov; 72(3):404-412. PubMed ID: 30388409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple and effective genotyping workflow for rapid detection of CRISPR genome editing.
    Wang L; Wang J; Feng D; Wang B; Jahan-Mihan Y; Wang Y; Bi Y; Lim D; Ji B
    Am J Physiol Gastrointest Liver Physiol; 2024 Apr; 326(4):G473-G481. PubMed ID: 38410866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.
    Paquet D; Kwart D; Chen A; Sproul A; Jacob S; Teo S; Olsen KM; Gregg A; Noggle S; Tessier-Lavigne M
    Nature; 2016 May; 533(7601):125-9. PubMed ID: 27120160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls.
    Simkin D; Papakis V; Bustos BI; Ambrosi CM; Ryan SJ; Baru V; Williams LA; Dempsey GT; McManus OB; Landers JE; Lubbe SJ; George AL; Kiskinis E
    Stem Cell Reports; 2022 Apr; 17(4):993-1008. PubMed ID: 35276091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair.
    He X; Tan C; Wang F; Wang Y; Zhou R; Cui D; You W; Zhao H; Ren J; Feng B
    Nucleic Acids Res; 2016 May; 44(9):e85. PubMed ID: 26850641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient and allele-specific genome editing of disease loci in human iPSCs.
    Smith C; Abalde-Atristain L; He C; Brodsky BR; Braunstein EM; Chaudhari P; Jang YY; Cheng L; Ye Z
    Mol Ther; 2015 Mar; 23(3):570-7. PubMed ID: 25418680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR as a strong gene editing tool.
    Shen S; Loh TJ; Shen H; Zheng X; Shen H
    BMB Rep; 2017 Jan; 50(1):20-24. PubMed ID: 27616359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9-Edited Site Sequencing (CRES-Seq): An Efficient and High-Throughput Method for the Selection of CRISPR-Cas9-Edited Clones.
    Veeranagouda Y; Debono-Lagneaux D; Fournet H; Thill G; Didier M
    Curr Protoc Mol Biol; 2018 Jan; 121():31.14.1-31.14.11. PubMed ID: 29337372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining.
    Geisinger JM; Turan S; Hernandez S; Spector LP; Calos MP
    Nucleic Acids Res; 2016 May; 44(8):e76. PubMed ID: 26762978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Directed Gene Editing Catalyzes Precise Gene Segment Replacement
    Sansbury BM; Wagner AM; Tarcic G; Barth S; Nitzan E; Goldfus R; Vidne M; Kmiec EB
    CRISPR J; 2019 Apr; 2():121-132. PubMed ID: 30998096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimizing off-target effects in CRISPR-Cas9 genome editing.
    Chen SJ
    Cell Biol Toxicol; 2019 Oct; 35(5):399-401. PubMed ID: 31317359
    [No Abstract]   [Full Text] [Related]  

  • 19. gRNA-transient expression system for simplified gRNA delivery in CRISPR/Cas9 genome editing.
    Easmin F; Hassan N; Sasano Y; Ekino K; Taguchi H; Harashima S
    J Biosci Bioeng; 2019 Sep; 128(3):373-378. PubMed ID: 31010727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks.
    Yang H; Ren S; Yu S; Pan H; Li T; Ge S; Zhang J; Xia N
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.